Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of in vitro expansion, post-expansion mechanical strength, and drug release-Reference-Cited by-同舟云学术

Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of in vitro expansion, post-expansion mechanical strength, and drug release

Published:2023-10 Issue: Volume: Page:123428
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

H. Blaesi Aron,Saka Nannaji

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. The mechanical properties of cellular solids;Ashby;Metall. Trans. A,1983

2. Atkins, P.W., 1994. Physical Chemistry, fifth ed. Oxford University Press, Oxford, UK, pp. 227-228, 846-849.

3. Transport Phenomena;Bird,2002

4. Expandable fibrous dosage forms for prolonged drug delivery;Blaesi;Mater. Sci. Eng. C,2021

5. Expandable, dual-excipient fibrous dosage forms for prolonged delivery of sparingly soluble drugs;Blaesi;Int. J. Pharm.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amorphous solid dispersion of a binary formulation with felodipine and HPMC for 3D printed floating tablets;International Journal of Pharmaceutics;2024-06

2. Rolled-up gastroretentive oral dosages for controlled release of riboflavin and propranolol;Journal of Drug Delivery Science and Technology;2024-05

3. Withdrawal notice to: “Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of expansion, post-expansion mechanical strength, and drug release” [Int. J. Pharm. 653 (2024) 123428];International Journal of Pharmaceutics;2024-03